BioCentury
ARTICLE | Clinical News

Optro recombinant human hemoglobin: SMTG and partner Eli Lilly began a Phase II trial

July 15, 1996 7:00 AM UTC

Somatogen Inc. (SMTG), Boulder, Colo. Product: Optro recombinant human hemoglobin Indication: Blood loss of one to four units in elective surgery Status: SMTG and partner Eli Lilly began a Phase II tr...